| Literature DB >> 27760315 |
Franz Puttur1, Marcela Francozo2, Gülhas Solmaz1, Carlos Bueno3, Marc Lindenberg1, Melanie Gohmert1, Maxine Swallow1, Dejene Tufa4, Roland Jacobs4, Stefan Lienenklaus5, Anja A Kühl6, Lisa Borkner7, Luka Cicin-Sain7, Bernard Holzmann8, Hermann Wagner9, Luciana Berod1, Tim Sparwasser10.
Abstract
Cytomegalovirus (CMV) is an opportunistic virus severely infecting immunocompromised individuals. In mice, endosomal Toll-like receptor 9 (TLR9) and downstream myeloid differentiation factor 88 (MyD88) are central to activating innate immune responses against mouse CMV (MCMV). In this respect, the cell-specific contribution of these pathways in initiating anti-MCMV immunity remains unclear. Using transgenic mice, we demonstrate that TLR9/MyD88 signaling selectively in CD11c+ dendritic cells (DCs) strongly enhances MCMV clearance by boosting natural killer (NK) cell CD69 expression and IFN-γ production. In addition, we show that in the absence of plasmacytoid DCs (pDCs), conventional DCs (cDCs) promote robust NK cell effector function and MCMV clearance in a TLR9/MyD88-dependent manner. Simultaneously, cDC-derived IL-15 regulates NK cell degranulation by TLR9/MyD88-independent mechanisms. Overall, we compartmentalize the cellular contribution of TLR9 and MyD88 signaling in individual DC subsets and evaluate the mechanism by which cDCs control MCMV immunity.Entities:
Keywords: MCMV; NK cells; TLR9-MyD88 signaling; conventional DC; plasmacytoid DC
Mesh:
Substances:
Year: 2016 PMID: 27760315 DOI: 10.1016/j.celrep.2016.09.055
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423